Medicine & Health

A grant of nearly $800,000 will fund the development of an “AI Scientist” system aimed at improving biomedical research efficiency, with an initial focus on neurodegenerative disease.

In total, WashU startups received nearly $125,000 in funding during an event at the Skandalaris Center’s annual spring awards ceremony.

Goldwater Scholar and biology major Noah Kabbaj is on the front lines of research aimed at helping people overcome treatment-resistant mental health conditions, including severe depression. After graduating from WashU, Kabbaj plans to earn his PhD in neuroscience.

WashU Medicine researchers led by Ryan Raut show that it is possible to accurately predict the state of brain activity by tracking variations in an animal’s pupil dilation, suggesting that brain circuits and the body are more dynamic and interrelated than previously thought.

A passion for motorcycles and a background in neuroscience drove Catalina Bernabé Correa to join the lab of Ismael Seáñez at WashU McKelvey Engineering, where she is studying different neuro-rehabilitation strategies for individuals with spinal cord injuries. Bernabé is set to graduate in May with a bachelor’s degree in biomedical engineering.

WashU neuroscientist Todd Braver has been elected to the American Academy of Arts & Sciences, one of the nation’s most prestigious honorary societies.

A study led by WashU Medicine researchers reveals molecular insights into Alzheimer’s disease, Parkinson’s disease and other dementias that could lead to earlier, more precise diagnoses.

Researchers at WashU have won $2.7 million from the National Institutes of Health (NIH) for a five-year investigation into the power of sleep to prevent, delay and diminish Alzheimer’s and other neurodegenerative diseases.

WashU will launch a doctoral program in neuroengineering in fall 2027, one of only a few in the United States.

New research from WashU Medicine adds to growing evidence that helping brain cells break down and eliminate their own cellular waste is a promising treatment strategy for a variety of neurodegenerative diseases.